TLR4 and atherosclerosis: Furthermore, we found that CUMS-induced atherogenesis can be interfered by inhibitions of TLR4 and NF-κB. As our knowledge, this is the first evidence revealed that the activation of TLR4/NF-κB pathway may be associated with CUMS-induced development of atherosclerosis.